Li M, Bozzacco L, Hoffmann H, Breton G, Loschko J, Xiao J, et al. Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion. J Exp Med. 2016;213:2931-2947 pubmed

Dhondup Y, Sjaastad I, Scott H, Sandanger Ø, Zhang L, Haugstad S, et al. Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice. PLoS ONE. 2015;10:e0139715 pubmed publisher

Miró Julià C, Escoda Ferran C, Carrasco E, Moeller J, Vadekaer D, Gao X, et al. Expression of the innate defense receptor S5D-SRCRB in the urogenital tract. Tissue Antigens. 2014;83:273-85 pubmed publisher

Haxaire C, Hakobyan N, Pannellini T, Carballo C, MCILWAIN D, Mak T, et al. Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF? pathway. Blood. 2018;: pubmed publisher

Ortiz B, White J, Wu W, Chan T. Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis. Oncotarget. 2014;5:6976-82 pubmed

Mauer J, Chaurasia B, Goldau J, Vogt M, Ruud J, Nguyen K, et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15:423-30 pubmed publisher

Ryder M, Gild M, Hohl T, Pamer E, Knauf J, Ghossein R, et al. Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS ONE. 2013;8:e54302 pubmed publisher

Knauf J, Sartor M, Medvedovic M, Lundsmith E, Ryder M, Salzano M, et al. Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling. Oncogene. 2011;30:3153-62 pubmed publisher